AtaiBeckley (STU:B72) Short Interest


STU:B72 AtaiBeckley Inc STU:B72
51 GF Score
Price €3.45
GF Value €6.32
! 4 Warning Signs
View Full Analysis

What is AtaiBeckley Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:B72 vs GLUE, NUVB, BHVN: Short Interest Comparison

For the Biotechnology subindustry, AtaiBeckley's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AtaiBeckley Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AtaiBeckley's Short Interest distribution charts can be found below:

* The bar in red indicates where AtaiBeckley's Short Interest falls into.


STU:B72
51GF Score
AtaiBeckley Inc STU:B72
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtaiBeckley (STU:B72) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of €3.45 is trading 45.5% below its estimated GF Value™ of €6.32.

Key valuation signals for STU:B72:

  • Short Interest:
  • GF Value™: €6.32 vs. price of €3.45 (45.5% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the STU:B72 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtaiBeckley Business Description

Other Exchanges ATAI:USAB72:Germany
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
51GF Score

Get the complete analysis for STU:B72

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.45
Price
€6.32
GF Value